BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alavizadeh SH, Soltani F, Ramezani M. Recent Advances in Immunoliposome-Based Cancer Therapy. Curr Pharmacol Rep 2016;2:129-41. [DOI: 10.1007/s40495-016-0056-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kampel L, Goldsmith M, Ramishetti S, Veiga N, Rosenblum D, Gutkin A, Chatterjee S, Penn M, Lerman G, Peer D, Muhanna N. Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles. J Control Release 2021;337:378-89. [PMID: 34303750 DOI: 10.1016/j.jconrel.2021.07.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
2 Sandeep D, Alsawaftah NM, Husseini GA. Immunoliposomes: Synthesis, Structure, and their Potential as Drug Delivery Carriers. CCTR 2020;16:306-19. [DOI: 10.2174/1573394716666200227095521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kukkar D, Kukkar P, Kumar V, Hong J, Kim KH, Deep A. Recent advances in nanoscale materials for antibody-based cancer theranostics. Biosens Bioelectron 2020;173:112787. [PMID: 33190049 DOI: 10.1016/j.bios.2020.112787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Di J, Xie F, Xu Y. When liposomes met antibodies: Drug delivery and beyond. Adv Drug Deliv Rev 2020;154-155:151-62. [PMID: 32926944 DOI: 10.1016/j.addr.2020.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
5 Sevastre A, Horescu C, Carina Baloi S, Cioc CE, Vatu BI, Tuta C, Artene SA, Danciulescu MM, Tudorache S, Dricu A. Benefits of Nanomedicine for Therapeutic Intervention in Malignant Diseases. Coatings 2019;9:628. [DOI: 10.3390/coatings9100628] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
6 Wang Q, Chung CY, Rosenberg JN, Yu G, Betenbaugh MJ. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells. Methods Mol Biol 2018;1850:237-57. [PMID: 30242691 DOI: 10.1007/978-1-4939-8730-6_16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
7 Koloskova O, Gileva A, Drozdova M, Grechihina M, Suzina N, Budanova U, Sebyakin Y, Kudlay D, Shilovskiy I, Sapozhnikov A, Kovalenko E, Markvicheva E, Khaitov M. Effect of lipopeptide structure on gene delivery system properties: Evaluation in 2D and 3D in vitro models. Colloids and Surfaces B: Biointerfaces 2018;167:328-36. [DOI: 10.1016/j.colsurfb.2018.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]